Structure Therapeutics Inc. logo

Structure Therapeutics Inc.

GPCR | NASDAQ
Chart Builder DCF Calculator
$37.09
+$0.28 (+0.76%)
Sep 22, 2026, 10:52 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 1.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a -1.22M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-118.63M -89.65M 23.99M -73.79M -70.45M -56.31M -47.06M -45.84M -33.32M -32.02M -30.99M -26.15M -25.99M -19.65M -12.96M -12.69M -13.96M -12.95M -13.27M
Interest Income
n/a 13.64M 18.55M n/a 8.96M 9.59M 10.68M n/a 7.33M 6M 6.22M 2.69M 2.79M 1.7M 899.51K 349K 76K n/a 1.91
Pretax Income
-105.93M -76M 33.17M -65.6M -61.52M -46.74M -36.34M -33.89M -25.98M -26.01M -24.82M -23.46M -23.16M -17.95M -12.06M -12.34M -13.88M -13.02M -13.28M
Net Income
-106.16M -76.19M 33M -65.71M -61.66M -46.83M -36.48M -33.98M -26.03M -26.04M -24.5M -23.86M -23.28M -17.98M -10.36M -12.42M -13.95M -13.08M -15.43M
Selling & General & Admin
18.57M 22.87M 17.57M 14.8M 15.74M 13.44M 13.57M 13.24M 11.27M 11.34M 10.95M 8.63M 6.58M 6.51M 4.6M 3.53M 3.78M 4.46M 3.37M
Research & Development
100.06M 66.71M 68.69M 58.99M 54.71M 42.87M 33.49M 32.6M 22.05M 20.68M 20.04M 17.52M 19.41M 13.14M 8.36M 9.16M 10.18M 8.49M 9.91M
Other Expenses
n/a -1.15M -110.25M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
118.63M 88.43M -23.99M 73.79M 70.45M 56.31M 47.06M 45.84M 33.32M 32.02M 30.99M 26.15M 25.99M 19.65M 12.96M 12.69M 13.96M 12.95M 13.27M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 69K 1K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
118.63M 89.65M -23.99M 73.79M 70.45M 56.31M 47.06M 45.84M 33.32M 32.02M 30.99M 26.15M 25.99M 19.65M 12.96M 12.69M 13.96M 12.95M 13.27M
Income Tax Expense
234K 190.57K 170K 108K 139K 98K 136K 92K 53K 29K -312K 405K 118K 25K -180K 73K 64K 60K 81K
Shares Outstanding (Basic)
72.65M 72.44M 59.2M 58.49M 57.92M 57.35M 57.29M 57.21M 49.41M 46.57M 46.41M 38.32M 38.25M 37.42M 36.59M 39.12M 36.59M 36.59M 36.59M
Shares Outstanding (Diluted)
72.65M 72.44M 59.2M 58.49M 57.92M 57.35M 57.29M 57.21M 49.41M 46.57M 46.41M 38.32M 38.25M 37.42M 36.59M 39.12M 36.59M 36.59M 36.59M
EPS (Basic)
-1.47 -1.05 0.60 -1.11 -1.08 -0.81 -0.63 -0.60 -0.54 -0.57 -0.54 -0.63 -0.60 -0.48 -0.32 -1.27 -0.42 -0.36 -0.42
EPS (Diluted)
-1.47 -1.05 0.60 -1.11 -1.08 -0.81 -0.63 -0.60 -0.54 -0.57 -0.54 -0.63 -0.60 -0.48 -0.32 -1.27 -0.42 -0.36 -0.42
EBITDA
-105.93M -74.79M 33.59M -65.31M -61.23M -46.46M -36.07M -33.62M -25.75M -25.79M -24.74M -23.38M -23.09M -17.88M -11.98M -12.27M -13.83M -12.88M -13.21M
EBIT
-105.93M -76M 33.17M -65.6M -61.52M -46.74M -36.34M -33.89M -25.98M -26.01M -24.82M -23.46M -23.16M -17.95M -12.06M -12.34M -13.88M -12.95M -13.27M
Depreciation & Amortization
n/a 1.22M 412K 291K 291K 274K 273K 265K 232K 222K 72K 79K 74K 70K 72K 76K 59K 70K 66K

© 2026 bestshares.com. All rights reserved.